BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6534723)

  • 1. [Clinical phase II trial of a new antineoplastic drug, glyciphosphoramide (GPM)].
    Sun Y
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):375-8. PubMed ID: 6534723
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical phase I trial of a new anti-neoplastic drug--glyciphosphoramide].
    Sun Y
    Zhonghua Zhong Liu Za Zhi; 1984 Jul; 6(4):293-5. PubMed ID: 6525950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide].
    Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):273-6. PubMed ID: 6241067
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
    Cancer Clin Trials; 1980; 3(2):115-20. PubMed ID: 7428135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbreviated phase I clinical trial of i.v. mitozolomide.
    Joss RA; Ryssel HJ; Bischoff AK; Goldhirsch A; Brunner KW
    Cancer Treat Rep; 1986 Jun; 70(6):797-8. PubMed ID: 3524827
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study of the antitumor action of glyciphosphoramide].
    He S; Ji XJ; Zhu TX; Wang NG; Su XL; Cao FZ; Pan ZK; Li ZR; Bao TT; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):334-7. PubMed ID: 6241082
    [No Abstract]   [Full Text] [Related]  

  • 9. Glufosfamide (Baxter Oncology).
    Niculescu-Duvaz I
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1527-32. PubMed ID: 12431031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter clinical trial of the antitumor drug Dioxadet (phase II)].
    Gershanovich ML; Filov VA; Kotova DG; Stukov AN; Sokolov IuN; Ivin BA
    Vopr Onkol; 1998; 44(2):216-20. PubMed ID: 9615831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Harper HD; Kemeny NE; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
    Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I clinical trial of spirogermanium.
    Schein PS; Slavik M; Smythe T; Hoth D; Smith F; Macdonald JS; Woolley PV
    Cancer Treat Rep; 1980; 64(10-11):1051-6. PubMed ID: 7459890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
    Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combinations drug therapy in solid tumors].
    Madrigal PL; Pérez Manga S; Pérez Gómez FJ
    Acta Oncol (Madr); 1975 May; 10(2):101-8. PubMed ID: 1211112
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
    Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
    Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Perfect drug targeting. Glufosfamide a new derivative].
    Holzgrabe U
    Pharm Unserer Zeit; 2006; 35(2):158-9. PubMed ID: 16583570
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of spirogermanium for treatment of advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.